We are live on ! Find out more
PCAP

Pratt Collard Advisory Partners Portfolio holdings

AUM $150M
1-Year Est. Return 51.02%
This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+51.02%
3 Year Est. Return
+91.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$150M
AUM Growth
+$10.2M
Cap. Flow
+$1.84M
Cap. Flow %
1.23%
Top 10 Hldgs %
39.78%
Holding
100
New
3
Increased
32
Reduced
35
Closed
3

Top Buys

Rank Stock Value
1
DMRC icon
Digimarc Corp
DMRC
+$344K
2
CSCO icon
Cisco
CSCO
+$263K
3
CVS icon
CVS Health
CVS
+$260K
4
APD icon
Air Products & Chemicals
APD
+$258K
5
WST icon
West Pharmaceutical
WST
+$226K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$344K
2
KSU
Kansas City Southern
KSU
+$302K
3
EMR icon
Emerson Electric
EMR
+$249K
4
STT icon
State Street
STT
+$202K
5
OVV icon
Ovintiv
OVV
+$121K

Sector Composition

Rank Sector Weight
1 Technology 20.65%
2 Consumer Staples 18.73%
3 Healthcare 17%
4 Financials 13.77%
5 Communication Services 8.97%

No holdings matched the selected filter criteria.

1 2 3 4

Similar funds

GAM
Geier Asset Management Marriottsville, Maryland $143M AUM
WFWM
Wechter Feldman Wealth Management Parsippany, New Jersey $143M AUM 25.17% 1-Year Est. Return
TWP
Treybourne Wealth Planners Greenwood, Indiana $162M AUM
TCM
Taal Capital Management Boston, Massachusetts $122M AUM 50.45% 1-Year Est. Return
LWPC
Legacy Wealth Partners (California) Calabasas, California $180M AUM 48.85% 1-Year Est. Return
RGM
ROAM Global Management New York $117M AUM
SFSIG
San Francisco Sentry Investment Group San Francisco, California $192M AUM 276.26% 1-Year Est. Return
CCM
Coe Capital Management Highland Park, Illinois $106M AUM 53.24% 1-Year Est. Return

Pratt Collard Advisory Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Pratt Collard Advisory Partners held 100 positions worth $150M, up 7.3% from $140M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Pratt Collard Advisory Partners's Q2 2021 filing shows 3 new, 32 increased, 35 reduced and 3 closed positions. Its largest new stake was West Pharmaceutical: 685 shares worth $246K. The largest sale was AbbVie, an estimated $344K.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Pratt Collard Advisory Partners's largest Q2 2021 buy was West Pharmaceutical: 685 shares worth $246K.
  • Pratt Collard Advisory Partners added most to Digimarc Corp in Q2 2021, an estimated $344K increase.
  • Pratt Collard Advisory Partners's biggest Q2 2021 reduction was AbbVie, cutting an estimated $344K.
  • Pratt Collard Advisory Partners fully exited Kansas City Southern in Q2 2021, selling an estimated $302K.
  • Pratt Collard Advisory Partners's ten largest holdings make up 40% of its $150M portfolio in Q2 2021.
  • Pratt Collard Advisory Partners opened 3 new positions and closed 3 in Q2 2021.
  • Pratt Collard Advisory Partners's portfolio value rose 7.3% quarter-over-quarter to $150M.

Based on Pratt Collard Advisory Partners's 13F filing for Q2 2021, filed 14 Jul 2021.